• DrShuchiGautam

Indian pharmaceutical industry plays vital role in development of economy contributing towards the welfare of humanity and providing significant socioeconomic benefits to the society. Indian pharma industry has a strong global foothold with accounting about 2.4 percent of the global pharmaceutical industry in value terms and 10 percent in volume terms and is expected to expand at $55 billion by 2020.Corporate restructuring has emerged as powerful tool during last decade for companies to revive the performance in many aspects and to revive & realign themselves. Corporate restructuring always aims at improving on the quality which can be further quantified in measurable terms. Hardest challenge for corporate in present days is to sustain their position in the market profitably. The objective of the study was to study the inorganic growth strategies adopted by Indian pharmaceutical industry, reasons and impact of strategy on the financial performance.Finding of the research shows that synergies generated through the inorganic growth take a long run to show the impact on the financial performance.Asset sale and Merger and Acquisition has been the most preferred way of inorganic growth in pharmaceutical industry .According to analysts market penetration and gaining competitive edge in the market and sustaining its leadership position has emerged as the major reasons for the corporate to opt for the inorganic growth.To maintain its market leadership companies have to grow horizontally and appropriately restructure themselves as per the need of the hour. In today’s business environment companies can’t rely only on organic growth and due to this reasons more and more corporate are opting for inorganic growth.

Merger & Acquisition, inorganic growth .Financial performance

"Analytical Study Of Inorganic Growth In Pharmaceutical Industry", International Journal of Emerging Technologies and Innovative Research (www.jetir.org), ISSN:2349-5162, Vol.5, Issue 12, page no.264-268, December-2018, Available :http://www.jetir.org/papers/JETIRP006060.pdf

"Analytical Study Of Inorganic Growth In Pharmaceutical Industry", International Journal of Emerging Technologies and Innovative Research (www.jetir.org | UGC and issn Approved), ISSN:2349-5162, Vol.5, Issue 12, page no. pp264-268, December-2018, Available at : http://www.jetir.org/papers/JETIRP006060.pdf